About AZI
AZI is a company based in Bunker Hill (United States) founded in 2017 by Gregory W Brooksby and Clyde Jupiter. AZI has raised $58.33 million across 1 funding round. AZI offers products and services including Medical Isotopes. AZI operates in a competitive market with competitors including ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
- Headquarter Bunker Hill, United States
- Founders Gregory W Brooksby, Clyde Jupiter
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Arizona Isotopes Science Research Corp.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$58.33 M (USD)
in 1 rounds
-
Latest Funding Round
$58.33 M (USD), Series C
May 16, 2018
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AZI
AZI offers a comprehensive portfolio of products and services, including Medical Isotopes.
Products for developing and producing isotopes in nuclear medicine
Funding Insights of AZI
AZI has successfully raised a total of $58.33M through 1 strategic funding round. The most recent funding activity was a Series C round of $58.33 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by AZI
Investment portfolio details for AZI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AZI
Detailed financials for AZI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Azi Comparisons
Peer comparison for AZI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AZI
AZI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Disease-modifying treatments for neurodegenerative diseases are developed.
|
Detailed competitors of AZI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Azi
Complete news archive for AZI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AZI
AZI was founded in 2017 and raised its 1st funding round 1 year after it was founded.
AZI is headquartered in Bunker Hill, United States. It is registered at Bunker Hill, Illinois, United States.
Gregory W Brooksby is the current CEO of AZI. They have also founded this company.
AZI is a funded company, having raised a total of $58.33M across 1 funding round to date.
AZI was founded in 2017 and is based in Bunker Hill, United States. Operations focus on the development and production of radiopharmaceuticals within the medical imaging sector. A range of isotopes, including Strontium-82, Germanium-68, Iodine-123, and Actinium-225, is manufactured for diagnostic imaging and therapeutic applications. The portfolio supports clinical uses in nuclear medicine.
AZI offers Medical Isotopes.